AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
VIDAMED INC
Q · usd
SIC 3840 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI AK-1627B53568
1.06▼ 3.17 (-74.94%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
4.23
Day's Range
4.16 – 4.60
52-Week Range
2.04 – 6.21
Volume
338.9K
Avg Volume
3.2M
Share Statistics
Shares Outstanding
Employees
—
Exchange
Q
Listed
—
Share count as of August 14, 2026

VIDAMED INC (VIDA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about VIDAMED INC (VIDA)
What is VIDAMED INC's Market Cap?
VIDAMED INC's Market Cap is $15.5M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · VIDAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Revenue
Cost of revenue – exclusive of amortization of capitalized software costs shown separately
Depreciation Expense
Selling, General and Administrative Expense
General and Administrative
Total Operating Expenses
% of revenue553.5%389.8%
OPERATING LOSS
% of revenue-453.5%-289.8%
OTHER EXPENSE
Interest Expense—
Realized gain on bitcoin——
Unrealized loss (gain) on bitcoin—
Total other expenses (income)
NET LOSS
% of revenue-484.2%-363.4%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)